Marie Guillou, Author at ERN Skin

Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus

Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus

Marie Guillou2024-09-16T14:28:52+02:00

Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus

Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensusMarie Guillou2024-09-16T14:28:52+02:00

French Guidelines on Albinism

French Guidelines on Albinism

Marie Guillou2024-09-16T14:35:18+02:00

French Guidelines on Albinism

French Guidelines on AlbinismMarie Guillou2024-09-16T14:35:18+02:00

Webinar EB – Join the Meeting

Marie Guillou2021-06-29T17:39:48+02:00

ERN-Skin Webinar Combined cell and gene therapy for Epidermolysis Bullosa – Michele De Luca Chaired by Cristina Has (Freiburg) / Christine Bodemer (Paris) [...]

Webinar EB – Join the MeetingMarie Guillou2021-06-29T17:39:48+02:00

S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)

S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)

Marie Guillou2024-09-26T14:24:46+02:00

J Eur Acad Dermatol Venereol. 2021 Jun;35(6):1251-1277 S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology [...]

S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)Marie Guillou2024-09-26T14:24:46+02:00

Dermatitis herpetiformis guidelines – S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by EADV

Dermatitis herpetiformis guidelines – S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by EADV

Marie Guillou2024-09-16T14:55:45+02:00

Dermatitis herpetiformis guidelines – S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV).

Dermatitis herpetiformis guidelines – S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by EADVMarie Guillou2024-09-16T14:55:45+02:00

Hereditary palmoplantar keratoderma – phenotypes and mutations in 64 patients

Hereditary palmoplantar keratoderma – phenotypes and mutations in 64 patients

Marie Guillou2024-10-16T11:06:40+02:00

Publication - 2021 Apr 29. Hereditary palmoplantar keratoderma - phenotypes and mutations in 64 patients Authors L Harjama, V Karvonen, K [...]

Hereditary palmoplantar keratoderma – phenotypes and mutations in 64 patientsMarie Guillou2024-10-16T11:06:40+02:00

QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study

QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study

Marie Guillou2024-10-01T10:49:47+02:00

Publication - Epub 2020 Sep 16. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study [...]

QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical StudyMarie Guillou2024-10-01T10:49:47+02:00

Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire

Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire

Marie Guillou2024-10-01T10:50:35+02:00

Publication - Epub 2020 Sep 7. Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire [...]

Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaireMarie Guillou2024-10-01T10:50:35+02:00

Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients

Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients

Marie Guillou2024-10-16T11:06:59+02:00

Publication - 2021 Jan 9. Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients Authors [...]

Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 PatientsMarie Guillou2024-10-16T11:06:59+02:00

What causes hidradenitis suppurativa ?-15 years after

What causes hidradenitis suppurativa ?-15 years after

Marie Guillou2024-10-01T10:29:53+02:00

Publication - 2020 Dec. What causes hidradenitis suppurativa ? - 15 years after Authors Christos C Zouboulis, Farida Benhadou, Angel S [...]

What causes hidradenitis suppurativa ?-15 years afterMarie Guillou2024-10-01T10:29:53+02:00

About Marie Guillou